Nordic Bio-Graphite AB

Based in Sweden, Nordic Bio-Graphite AB specializes in producing bio-based, fossil-free graphite essential for various industries, including electric vehicles and steel manufacturing. Nordic Bio-Graphite AB, founded in 2024, is headquartered in Stockholm, Sweden, and focuses on developing sustainable graphite solutions. In December 2025, Nordic Bio-Graphite AB raised EUR 600,000 in venture funding from EIT RawMaterials, European Innovation Council, Norrsken VC, and European Investment Fund. Nordic Bio-Graphite specializes in the development and production of bio-based, fossil-free graphite, a critical material for a variety of industries including electric vehicles (EVs), steel manufacturing, fuel cells, nuclear energy, and aluminum production.

Their core offerings include high-purity graphite suitable for anode materials in lithium-ion batteries and electrodes for steel production, boasting a purity level of over 99. 95%. The company utilizes a patented production process that leverages biocarbon as a feedstock, achieving a 70% reduction in energy consumption and a 95% decrease in chemical usage compared to traditional graphite production methods. The products are primarily targeted at markets within Europe, addressing the increasing demand for sustainable materials amid supply chain challenges and reliance on imports.

Clients include manufacturers in the EV sector, steel producers, and research institutions focused on innovative energy solutions, all seeking to reduce their carbon footprint and enhance the sustainability of their operations. The revenue model of Nordic Bio-Graphite revolves around B2B transactions with clients across various sectors, including steel manufacturing, battery production, and energy storage solutions. The company engages in direct sales of its high-purity bio-graphite products, entering partnerships and collaborations to supply materials tailored to specific applications and industry needs. Transactions typically occur on a contract basis, where clients procure graphite based on their operational requirements, potentially involving bulk orders at negotiated pricing plans.

The focus on high-quality graphite production, validated through rigorous testing and independent verification, positions Nordic Bio-Graphite to secure long-term agreements with key players in the industry, enhancing their revenue streams through consistent demand for their flagship graphite solutions. The company will use the December 2025 funding to validate market demand and advance plans for its first pilot plant.